Cyclacel Pharmaceuticals Inc (CYCC)
2.00
-0.49
(-19.68%)
USD |
NASDAQ |
May 03, 16:00
2.02
+0.02
(+1.00%)
After-Hours: 20:00
Cyclacel Pharmaceuticals Cash and Short Term Investments (Quarterly): 3.378M for Dec. 31, 2023
Cash and Short Term Investments (Quarterly) Chart
Historical Cash and Short Term Investments (Quarterly) Data
| Date | Value |
|---|---|
| December 31, 2023 | 3.378M |
| September 30, 2023 | 5.944M |
| June 30, 2023 | 10.16M |
| March 31, 2023 | 11.44M |
| December 31, 2022 | 18.34M |
| September 30, 2022 | 23.71M |
| June 30, 2022 | 29.08M |
| March 31, 2022 | 29.64M |
| December 31, 2021 | 36.56M |
| September 30, 2021 | 40.22M |
| June 30, 2021 | 43.64M |
| March 31, 2021 | 47.78M |
| December 31, 2020 | 33.41M |
| September 30, 2020 | 23.13M |
| June 30, 2020 | 25.34M |
| March 31, 2020 | 8.923M |
| December 31, 2019 | 11.88M |
| September 30, 2019 | 12.97M |
| June 30, 2019 | 15.16M |
| March 31, 2019 | 17.93M |
| December 31, 2018 | 17.50M |
| September 30, 2018 | 18.97M |
| June 30, 2018 | 19.82M |
| March 31, 2018 | 21.72M |
| December 31, 2017 | 23.91M |
| Date | Value |
|---|---|
| September 30, 2017 | 26.02M |
| June 30, 2017 | 13.59M |
| March 31, 2017 | 12.73M |
| December 31, 2016 | 16.52M |
| September 30, 2016 | 18.03M |
| June 30, 2016 | 15.93M |
| March 31, 2016 | 17.12M |
| December 31, 2015 | 20.44M |
| September 30, 2015 | 22.73M |
| June 30, 2015 | 26.90M |
| March 31, 2015 | 29.36M |
| December 31, 2014 | 24.19M |
| September 30, 2014 | 26.71M |
| June 30, 2014 | 33.58M |
| March 31, 2014 | 28.15M |
| December 31, 2013 | 31.15M |
| September 30, 2013 | 34.49M |
| June 30, 2013 | 33.67M |
| March 31, 2013 | 14.14M |
| December 31, 2012 | 16.41M |
| September 30, 2012 | 17.84M |
| June 30, 2012 | 19.96M |
| March 31, 2012 | 23.64M |
| December 31, 2011 | 24.45M |
| September 30, 2011 | 27.68M |
Cash and Short Term Investments Definition
Cash and Short Term investments is the sum of two balance sheet line items: cash and equivalents and short term investments in marketable securities.
Cash and Short Term Investments (Quarterly) Range, Past 5 Years
3.378M
Minimum
Dec 2023
47.78M
Maximum
Mar 2021
22.67M
Average
23.13M
Median
Sep 2020
Cash and Short Term Investments (Quarterly) Benchmarks
| Corvus Pharmaceuticals Inc | 27.15M |
| Oragenics Inc | 3.484M |
| Relmada Therapeutics Inc | 96.32M |
| Alpine Immune Sciences Inc | 327.41M |
| MAIA Biotechnology Inc | 7.151M |